Literature DB >> 10425612

Clinical practice guidelines for the management of anemia coexistent with chronic renal failure. Canadian Society of Nephrology.

B J Barrett, S S Fenton, B Ferguson, P Halligan, S Langlois, W G Mccready, N Muirhead, R V Weir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10425612

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  8 in total

Review 1.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 2.  Kidney disease: improving global outcomes.

Authors:  Kai-Uwe Eckardt; Bertram L Kasiske
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

3.  C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.

Authors:  Iain C Macdougall; Rowan Walker; Robert Provenzano; Fernando de Alvaro; Harold R Locay; Paul C Nader; Francesco Locatelli; Frank C Dougherty; Ulrich Beyer
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

4.  Preoperative hemoglobin and outcomes in patients with CKD undergoing cardiac surgery.

Authors:  Linda Shavit; Sharbel Hitti; Shuli Silberman; Rachel Tauber; Ofer Merin; Meyer Lifschitz; Itzchak Slotki; Daniel Bitran; Daniel Fink
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

5.  An update on the controversies in anemia management in chronic kidney disease: lessons learned and lost.

Authors:  Geoffrey Teehan; Robert L Benz
Journal:  Anemia       Date:  2011-04-10

6.  Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor.

Authors:  Biagio R Di Iorio; Pasquale Guastaferro; Nicola Cillo; Emanuele Cucciniello; Vincenzo Bellizzi
Journal:  Drug Target Insights       Date:  2007-01-24

7.  [Predictors of response to the CERA in chronic hemodialysis treatment-naive by erythropoiesis-stimulating agent].

Authors:  Mariam Ezziani; Adil Najdi; Souad Mikou; Hakim Hanin; Mohammed Arrayhani; Tarik Sqalli Houssaini
Journal:  Pan Afr Med J       Date:  2015-04-07

8.  Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Authors:  Katherine A Barraclough; Euan Noble; Diana Leary; Fiona Brown; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; David W Mudge; Carolyn L van Eps; Joanna M Sturtevant; David W Johnson
Journal:  BMC Nephrol       Date:  2009-07-28       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.